期刊文献+

AMP579与腺苷对大鼠心室肌细胞Na^+/Ca^(2+)交换电流作用的比较(英文) 被引量:1

Comparison between effects of AMP579 and adenosine on Na^+/Ca^(2+) exchanger in isolated rat ventricular myocytes
暂未订购
导出
摘要 目的阐明AMP579与腺苷不同药理作用与临床效果的机制。方法采用全细胞膜片钳记录Na+/Ca2 +交换电流。结果AMP579对Na+/Ca2 +交换的外向和内向电流均呈浓度依赖性增强。灌流腺苷A1受体阻断剂PD116948 30μmol·L-1,A2受体阻断剂DMPX10μmol·L-1,蛋白激酶A特异阻断剂KT5720 0 .2μmol·L-1或蛋白激酶C特异阻断剂GF109203X0 .4μmol·L-1对AMP579 Na+/Ca2 +交换电流的激动作用均无影响,提示AMP579对Na+/Ca2 +交换电流具有直接的激动作用。结论AMP579对Na+/Ca2 +交换电流可能具有直接的激动作用。 AIM To elucidate possible mechanisms underlying the differences between 1 S-[1 a, 2b, 3b, 4a ( S* )]-4-[ 7-I[ 1-( 3-chloro-2-thienyl ) methylpmpyl ] pmpyl-amino ]-3H-imidazo [ 4, 5-b ] pyridyl-3-yl]-N- ethyl-2, 3-dihydroxycyclopentane carboxamide ( AMP- 579) and adenosine in pharmacological and clinical effects. METHODS Na^+/Ca^2+ exchange current was recorded by patch-clamp technique in whole-cell cortfiguration. RESULTS AMP579 significantly enhanced both outward and inward Na^+/Ca^2+ exchange currents in a concentration dependent manner. Neither infusion of an adenosine Al receptor antagonist PD116948 30μmol· L^-1 or an adenosine A2 receptor antagonist DMPX 10μmol· L^-1 nor a protein kinase A special blocker KT 5720 0.2μmol· L^-1 or a protein kinase C special blocker GF 109203X 0. 4 μmol· L^-1 had effect on Na^+/Ca^2+ exchange current increased by AMP579, suggesting that AMP579 possess a direct activating effect on Na^+/Ca^2+ exchange possesses current. current a direct CONCLUSION AMP579 possibly activating effect on Na^+/Ca^2+ exchange current.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2005年第4期254-258,共5页 Chinese Journal of Pharmacology and Toxicology
关键词 AMP579 心肌 腺苷 钠/钙交换电流 膜片钳技术 全细胞 AMP579 myocardium adenosine sodium/calcium exchange current patch clamp technique, wholecell
  • 相关文献

参考文献15

  • 1Verani MS. Adenosine thallium 201 myocardial perfusion scintigraphy[J]. Am Heart J, 1991, 122(1 Pt 1) :269 -278 ; discussion 302 - 306.
  • 2Pelleg A, Belardinelli L. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects[J].Cardiovasc Res, 1993, 27(1):54-61.
  • 3Goto M, Miura T, Iliodoromitis EK, O'Leary EL, Ishimoto R, Yellon DM, et al. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species[J].Cardiovasc Res, 1991, 25(11 ) :943 - 949.
  • 4Pitarys CJ 2nd, Virmani R, Vildibill HD Jr, Jackson EK,Forman MB. Reduction of myocardial reperfusion injury, by intravenous adenosine administered during the early reperfusion period[J]. Circulation, 1991, 83(1 ) :237 - 247.
  • 5Nakamura M, Zhao ZQ, Clark KL, Velez DV, Guyon RA, Vinten-Johansen J. A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelimn[J]. Eur J Pharmacol, 2000, 397(1):197-205.
  • 6Kis A, Baxter GF, Yellon DM. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erkl/2[J].Card/ovasc Drugs Ther, 2003, 17(5 - 6) :415 - 425.
  • 7Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D,Frommell G, et al. AmP579 Delivery for Myocardial Infarction Reduction study. A randomized, double-blinded,placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AMP579 Delivery for Myocardial Infarction Reduction) study[J]. Am Heart J, 2003, 146(1):146- 152.
  • 8Freilich A, Tepper D. Adenosine and its cardiovascular effects[J]. Am Heart J, 1992, 123(5) : 1324 - 1328.
  • 9Coetzee WA, Ichikawa H, Hearse DJ. Oxidant stress inhibits Na-Ca-exchange current in cardiac myocytes: mediation by sulfhydryl groups[J]? Am J Physiol, 1994, 266(3h 2) :H909 - H919.
  • 10Blaustein MP, Lederer WJ. Sodimn/calcium exchange: its physiological implications[J]. Physiol Rev, 1999, 79(3) :763 - 854.

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部